MACROGENICS, INC. Deferred Tax Assets, Property, Plant and Equipment
MACROGENICS, INC. (MGNX) had Deferred Tax Assets, Property, Plant and Equipment of $158.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment · last filed 2023-03-15
- 2022-12-31: Deferred Tax Assets, Property, Plant and Equipment $158.00K.
- 2021-12-31: Deferred Tax Assets, Property, Plant and Equipment $0.00.
- 2018-12-31: Deferred Tax Assets, Property, Plant and Equipment $0.00.
- 2017-12-31: Deferred Tax Assets, Property, Plant and Equipment $155.00K.
| Period end | Deferred Tax Assets, Property, Plant and Equipment | Deferred Tax Assets, Property, Plant and Equipment as first filed |
|---|---|---|
| 2022-12-31 | $158.00K 10-K · filed 2023-03-15 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-15 | |
| 2018-12-31 | $0.00 10-K · filed 2019-02-26 | |
| 2017-12-31 | $155.00K 10-K · filed 2019-02-26 | |
| 2016-12-31 | $2.93M 10-K · filed 2018-02-27 | |
| 2015-12-31 | $1.60M 10-K · filed 2017-02-28 | |
| 2014-12-31 | $1.34M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $1.44M 10-K · filed 2015-03-03 | $1.44M 10-K · filed 2014-03-20 |
| 2012-12-31 | $1.25M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |